XSpray Pharma AB (XSPRAY) — Working Capital to Net Assets Ratio
XSpray Pharma AB (XSPRAY) has a Working Capital to Net Assets ratio of 0.6% as of March 2026. Working capital of Skr3.27 Million (current assets of Skr149.92 Million minus current liabilities of Skr146.64 Million) is measured against net assets of Skr569.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See XSpray Pharma AB (XSPRAY) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
XSpray Pharma AB Working Capital to Net Assets (2015–2025)
This chart shows how XSpray Pharma AB's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 0.6%, reflecting working capital of Skr3.27 Million against net assets of Skr569.36 Million SEK. Check XSpray Pharma AB tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for XSpray Pharma AB (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for XSpray Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see XSPRAY stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.7% | Skr161.23 Million | Skr604.65 Million | Skr182.90 Million | Skr21.66 Million | ▲ +12.4 pp |
| 2024 | 14.3% | Skr88.93 Million | Skr623.10 Million | Skr235.07 Million | Skr146.14 Million | ▼ -11.4 pp |
| 2023 | 25.7% | Skr177.91 Million | Skr693.41 Million | Skr217.81 Million | Skr39.90 Million | ▲ +7.1 pp |
| 2022 | 18.6% | Skr103.38 Million | Skr556.02 Million | Skr132.23 Million | Skr28.85 Million | ▼ -24.0 pp |
| 2021 | 42.6% | Skr252.10 Million | Skr591.75 Million | Skr282.06 Million | Skr29.97 Million | ▼ -10.8 pp |
| 2020 | 53.4% | Skr311.20 Million | Skr582.59 Million | Skr331.01 Million | Skr19.82 Million | ▲ +1.6 pp |
| 2019 | 51.8% | Skr193.62 Million | Skr373.71 Million | Skr216.13 Million | Skr22.50 Million | ▼ -19.8 pp |
| 2018 | 71.6% | Skr216.09 Million | Skr301.72 Million | Skr226.86 Million | Skr10.77 Million | ▼ -0.1 pp |
| 2017 | 71.7% | Skr111.59 Million | Skr155.66 Million | Skr117.34 Million | Skr5.75 Million | ▲ +16.0 pp |
| 2016 | 55.7% | Skr25.87 Million | Skr46.47 Million | Skr31.26 Million | Skr5.39 Million | ▼ -30.8 pp |
| 2015 | 86.5% | Skr10.61 Million | Skr12.26 Million | Skr13.29 Million | Skr2.69 Million | — |